These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 24465696)

  • 21. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of autophagic flux by epigallocatechin gallate mitigates TRAIL-induced tumor cell apoptosis via down-regulation of death receptors.
    Kim SW; Moon JH; Park SY
    Oncotarget; 2016 Oct; 7(40):65660-65668. PubMed ID: 27582540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
    Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
    J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy.
    Lee SC; Kim KH; Kim OH; Lee SK; Hong HE; Choi BJ; Jeong W; Kim SJ
    Cancer Res Treat; 2018 Jul; 50(3):1023-1038. PubMed ID: 29121714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models.
    Adiseshaiah PP; Clogston JD; McLeland CB; Rodriguez J; Potter TM; Neun BW; Skoczen SL; Shanmugavelandy SS; Kester M; Stern ST; McNeil SE
    Cancer Lett; 2013 Sep; 337(2):254-65. PubMed ID: 23664889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.
    Wen Y; Zhao RQ; Zhang YK; Gupta P; Fu LX; Tang AZ; Liu BM; Chen ZS; Yang DH; Liang G
    Oncotarget; 2017 May; 8(18):29760-29770. PubMed ID: 28423656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells.
    Saha SK; Yin Y; Kim K; Yang GM; Dayem AA; Choi HY; Cho SG
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
    Guo L; Li H; Fan T; Ma Y; Wang L
    Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin.
    Gambari R; Hau DK; Wong WY; Chui CH
    Phytother Res; 2014 May; 28(5):781-3. PubMed ID: 23913631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway.
    He H; He M; Wang Y; Xiong H; Xiong Y; Shan M; Liu D; Guo Z; Kou Y; Zhang Y; Yang M; Lian J; Sun L; He F
    Exp Cell Res; 2024 Jun; 439(1):114094. PubMed ID: 38750718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.
    Wei R; Mao L; Xu P; Zheng X; Hackman RM; Mackenzie GG; Wang Y
    Food Funct; 2018 Nov; 9(11):5682-5696. PubMed ID: 30310905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
    Flores-Pérez A; Marchat LA; Sánchez LL; Romero-Zamora D; Arechaga-Ocampo E; Ramírez-Torres N; Chávez JD; Carlos-Reyes Á; Astudillo-de la Vega H; Ruiz-García E; González-Pérez A; López-Camarillo C
    Proteomics Clin Appl; 2016 Feb; 10(2):172-82. PubMed ID: 26175166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy.
    Xiao MC; Qian H; Huang CK; Zheng BN; Yan FZ; Liu F; Zhang X; Chen SJ; Luo C; Xie WF
    Eur J Pharmacol; 2021 Sep; 906():174217. PubMed ID: 34087223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft.
    Zhang Q; Wei D; Liu J
    Cancer Lett; 2004 May; 208(2):179-86. PubMed ID: 15142676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells.
    Zhou Y; Chen E; Tang Y; Mao J; Shen J; Zheng X; Xie S; Zhang S; Wu Y; Liu H; Zhi X; Ma T; Ni H; Chen J; Chai K; Chen W
    Cell Death Dis; 2019 Nov; 10(11):843. PubMed ID: 31695022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor.
    Zeng X; Zhang H; Oh A; Zhang Y; Yee D
    Breast Cancer Res Treat; 2012 May; 133(1):117-26. PubMed ID: 21850397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green Tea Catechin-Based Complex Micelles Combined with Doxorubicin to Overcome Cardiotoxicity and Multidrug Resistance.
    Cheng T; Liu J; Ren J; Huang F; Ou H; Ding Y; Zhang Y; Ma R; An Y; Liu J; Shi L
    Theranostics; 2016; 6(9):1277-92. PubMed ID: 27375779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-based discovery of small molecules suppressing cancer cell proliferation via autophagic flux inhibition.
    Liu L; Tian Z; Zhang Y; Liu P; Xin Z; Zhao Y; Li Y; Miao S; Shi J; Chen Z; Liu J; Zhang H
    J Mol Med (Berl); 2020 Nov; 98(11):1573-1589. PubMed ID: 32897390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.